Q1 2026 GE Healthcare Technologies Inc Earnings Call Transcript
Key Points
- GE HealthCare Technologies Inc (GEHC) reported top-line growth at the high end of expectations, driven by strong performance in Pharmaceutical Diagnostics, Advanced Visualization Solutions, and Imaging businesses.
- The company saw double-digit reported growth in EMEA and Rest of World, with mid-single-digit growth in the US and China sales aligning with expectations.
- GEHC achieved significant regulatory milestones, including FDA clearances for new MR technologies and Photonova Spectra, a differentiated Photon Counting CT platform.
- The company completed the acquisition of Intelerad, enhancing its cloud and software capabilities, and advancing its strategy to deliver a connected enterprise imaging ecosystem.
- GEHC is making progress in developing a novel gadolinium-free MRI contrast agent, which has received FDA Fast Track designation, potentially accelerating its market entry.
- Profit performance was disappointing due to a recall associated with a PDx supplier and significant increases in material costs, leading to a reduction in profit and free cash flow guidance for 2026.
- The company faced a $250 million gross inflation impact, primarily due to increased costs of memory chips, oil, and freight, which affected profit margins.
- Adjusted EBIT margin declined by approximately 150 basis points year-over-year, impacted by tariff expenses and declines in PCS and PDx supplier issues.
- Patient Care Solutions (PCS) experienced an 8.1% year-over-year decline in organic revenue, attributed to delayed large monitoring installations and tariff impacts.
- GEHC reduced its full-year adjusted EPS guidance due to inflationary pressures, with expectations of mid- to high-single-digit adjusted EPS growth.
Good day, and thank you for standing by. Welcome to the GE HealthCare first-quarter 2026 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. Now it's my pleasure to hand the conference over to Carolynne Borders. Please proceed.
Thanks, operator. Good morning, and welcome to GE HealthCare's first-quarter 2026 earnings call. I'm joined by our President and CEO, Peter Arduini; and Vice President and CFO, Jay Saccaro. Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website.
During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties. With that, I'll turn the call over to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
